-
RKDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arcadia Biosciences (RKDA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.94 mm | 3.94 mm | 3.94 mm | 3.94 mm | 3.94 mm | |
Cash burn (monthly) | (no burn) | 795.67 k | 586.67 k | 1.27 mm | 853.83 k | |
Cash used (since last report) | n/a | 2.23 mm | 1.64 mm | 3.56 mm | 2.39 mm | |
Cash remaining | n/a | 1.71 mm | 2.29 mm | 376.33 k | 1.54 mm | |
Runway (months of cash) | n/a | 2.1 | 3.9 | 0.3 | 1.8 |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 2 |
Closed positions | 7 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 41.38 mm |
Total shares | 2.20 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Moral Compass | 1.13 mm | $0.00 |
Intracoastal Capital | 1.06 mm | $1.10 mm |
STT State Street | 12.15 k | $38.26 mm |
MS Morgan Stanley | 607.00 | $1.91 mm |
Group One Trading | 18.00 | $57.00 k |
BAC Bank of America | 11.00 | $35.00 k |
Oliver Lagore Vanvalin Investment | 4.00 | $13.00 k |
RY Royal Bank of Canada | 2.00 | $0.00 |
Harbour Investments | 1.00 | $3.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Aug 24 | Carosella Deborah D | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 10,909 | 29.56 k | 13,255 |
19 Aug 24 | Mark Kawakami | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 20,000 | 54.20 k | 21,487 |
19 Aug 24 | Thomas J. Schaefer | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 20,000 | 54.20 k | 25,475 |
19 Aug 24 | Comcowich Kevin | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 25,455 | 68.98 k | 31,042 |
19 Aug 24 | Yoder Amy | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 10,909 | 29.56 k | 13,442 |